Overview
Yongmin Tang practices in Hangzhou, China. Tang is rated as an Advanced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Their top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.
Their clinical research consists of co-authoring 117 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 26 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hemophagocytic Lymphohistiocytosis
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Aplastic AnemiaTang isAdvanced. Learn about Aplastic Anemia.
- Childhood Acute Myeloid Leukemia
- HistiocytosisTang isAdvanced. Learn about Histiocytosis.
- LeukemiaTang isAdvanced. Learn about Leukemia.
- Non-Langerhans-Cell Histiocytosis
- Experienced
- Aase SyndromeTang isExperienced. Learn about Aase Syndrome.
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia
- AgranulocytosisTang isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell Lymphoma
- AnemiaTang isExperienced. Learn about Anemia.